Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

HWK-007

Antibody-drug conjugate · Kills target cells, directed at protein tyrosine kinase 7 (PTK7) · developed by Whitehawk Therapeutics

Phase 1 Most advanced trial
WHWK Developer
1 Registered trials

What is HWK-007?

HWK-007 is an antibody-drug conjugate that binds PTK7, a tumor-associated antigen overexpressed on various cancer cells, and carries an undisclosed cytotoxic payload. After binding and internalization, the payload induces apoptosis in PTK7-overexpressing tumor cells. It is being studied in solid tumors, including endometrial, ovarian and non-small cell lung cancers.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Antibody-drug conjugate
Targets
protein tyrosine kinase 7 (PTK7)
Mechanism
Kills target cells, directed at protein tyrosine kinase 7 (PTK7)
Pathways
apoptosis
Therapy area
Oncology
Developer
Whitehawk Therapeutics, Inc. (WHWK)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07444814 Phase 1 Endometrial Cancer Recruiting WHWK

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Endometrial CancerNon-squamous EGFR Wt NSCLCOvarian CancerOvarian Cancer MetastaticOvarian Cancer Metastatic RecurrentPlatinum Resistant Ovarian CancerPROC

Other drugs acting on PTK7

More from Whitehawk Therapeutics

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the WHWK page.

Follow WHWK, the company behind HWK-007

See WHWK's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

WHWK catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.